Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Measuring Silent Disease Progression in Multiple Sclerosis With a Multimodal ApproachRecruiting
NCT06501950N/AUpdated Jul 15, 2024
Sponsor: Heinrich-Heine University, Duesseldorf
Multiple Sclerosis
Germany
Reliability and Validity of Outcome Measures for Pain in Multiple SclerosisCompleted
NCT05742152N/AUpdated Jul 12, 2024
Sponsor: Hasselt University
Pain
Belgium, Chile
Effectiveness of Acupuncture Treatment Applied in Addition to the Rehabilitation Program in Multiple Sclerosis PatientsCompleted
NCT06178029NAUpdated Jul 12, 2024
Sponsor: Ankara City Hospital Bilkent
Multiple Sclerosis
Turkey (Türkiye)
A Comprehensive Assessment of Trunk, Scapula and Upper Limb in Neurological Patients. Reliability, Validity and InterrelatednessCompleted
NCT04908891NAUpdated Jul 12, 2024
Sponsor: Hasselt University
Multiple Sclerosis · Stroke
Belgium
Comparing Transanal Irrigation With Navina Smart vs. Standard Bowel Care in Patients With Multiple SclerosisUnknown
NCT04707976NAUpdated Jul 11, 2024
Sponsor: Wellspect HealthCare
Neurogenic Bowel (Disorder) · Fecal Constipation · Fecal Incontinence · Multiple Sclerosis
Denmark, France, Italy, Spain, Switzerland +1 more
Computer Assisted Cognitive Rehabilitation for Persons With Multiple SclerosisCompleted
NCT03200899NAUpdated Jul 10, 2024
Sponsor: University of Texas at Austin
Multiple Sclerosis
United States
Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic NeuritisUnknown
NCT06494228N/AUpdated Jul 10, 2024
Sponsor: University Hospital, Strasbourg, France
Multiple Sclerosis · Demyelinating Diseases
France
Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS)Terminated
NCT03049969NAUpdated Jul 9, 2024
Sponsor: NYU Langone Health
Multiple Sclerosis · Neurological Disorder
United States
Gait Analysis in Multiple Sclerosis PatientsCompleted
NCT05299151NAUpdated Jul 9, 2024
Sponsor: Istanbul Kültür University
Multiple Sclerosis · 3D Gait Analysis · Vestibular Rehabilitation
Turkey (Türkiye)
Pregnancy Cohort in Multiple Sclerosis (MS)Recruiting
NCT05010902N/AUpdated Jul 5, 2024
Sponsor: Charite University, Berlin, Germany
Multiple Sclerosis (MS) · Clinically Isolated Syndrome (CIS)
Germany
Telerehabilitation in Progressive Multiple SclerosisUnknown
NCT06485115NAUpdated Jul 3, 2024
Sponsor: Universita di Verona
Progressive Multiple Sclerosis
Italy
Strategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation in Multiple SclerosisRecruiting
NCT06461481N/AUpdated Jul 3, 2024
Sponsor: Heinrich-Heine University, Duesseldorf
Multiple Sclerosis
Germany
Effectiveness of Task Specific Home Exercise ProgramUnknown
NCT06486116NAUpdated Jul 3, 2024
Sponsor: New York Presbyterian Brooklyn Methodist Hospital
Multiple Sclerosis
United States
PET Imaging of Cyclooxygenase in Multiple SclerosisTerminated
NCT05062083Phase 2Updated Jun 27, 2024
Sponsor: National Institute of Mental Health (NIMH)
Multiple Sclerosis
United States
Effects of Resistance Training in Multiple Sclerosis: a Randomized Trial.Unknown
NCT06478784NAUpdated Jun 27, 2024
Sponsor: Hospital Clínico Universitario de Valladolid
Multiple Sclerosis
Spain
Remote Evaluation of MIND DietRecruiting
NCT06450977NAUpdated Jun 27, 2024
Sponsor: University of Illinois at Urbana-Champaign
Multiple Sclerosis · Cognitive Change · Nutrition, Healthy
United States
Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in WomenUnknown
NCT05439902NAUpdated Jun 25, 2024
Sponsor: Centre Hospitalier Universitaire de Nīmes
Multiple Sclerosis · Dysuria · Lower Urinary Tract Symptoms · Voiding Dysfunction
France
Pelvic Floor Disorders in Multiple Sclerosis PatientsUnknown
NCT06473753N/AUpdated Jun 25, 2024
Sponsor: Assiut University
Multiple Sclerosis
A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)Terminated
NCT05532163Phase 4Updated Jun 21, 2024
Sponsor: Biogen
Multiple Sclerosis, Relapsing-Remitting
Germany
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS PatientsCompleted
NCT03623243Phase 3Updated Jun 20, 2024
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis · Relapsing Multiple Sclerosis · Advancing Multiple Sclerosis
United States, Puerto Rico
Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)Completed
NCT04792567Phase 4Updated Jun 20, 2024
Sponsor: Novartis Pharmaceuticals
Secondary Progressive Multiple Sclerosis
Germany
Cerebellar tDCS and Balance Training in PwMSCompleted
NCT04391023NAUpdated Jun 18, 2024
Sponsor: University of Iowa
Multiple Sclerosis
United States
Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying TherapiesCompleted
NCT06459232N/AUpdated Jun 14, 2024
Sponsor: Novartis
Multiple Sclerosis
United States
A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With OfatumumabCompleted
NCT06460324N/AUpdated Jun 14, 2024
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple SclerosisCompleted
NCT05046535N/AUpdated Jun 14, 2024
Sponsor: University of Jordan
Multiple Sclerosis
Jordan

Previous page Next page